Page last updated: 2024-11-03

procainamide and Lung Neoplasms

procainamide has been researched along with Lung Neoplasms in 3 studies

Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.

Lung Neoplasms: Tumors or cancer of the LUNG.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, Z1
Xu, Z1
Hung, MS1
Lin, YC1
Wang, T1
Gong, M1
Zhi, X1
Jablons, DM1
You, L1
Giannone, L1
Kugler, JW1
Krantz, SB1

Other Studies

3 other studies available for procainamide and Lung Neoplasms

ArticleYear
Procaine and procainamide inhibit the Wnt canonical pathway by promoter demethylation of WIF-1 in lung cancer cells.
    Oncology reports, 2009, Volume: 22, Issue:6

    Topics: Adaptor Proteins, Signal Transducing; Anesthetics, Local; Anti-Arrhythmia Agents; Cell Line, Tumor;

2009
Pure red cell aplasia associated with administration of sustained-release procainamide.
    Archives of internal medicine, 1987, Volume: 147, Issue:6

    Topics: Aged; Anemia, Aplastic; Carcinoma, Small Cell; Delayed-Action Preparations; Drug Therapy, Combinatio

1987
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 21-1968.
    The New England journal of medicine, 1968, May-23, Volume: 278, Issue:21

    Topics: Aged; Carcinoma, Squamous Cell; Diagnosis, Differential; Glomerulonephritis; Granuloma; Humans; Lung

1968